Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: - meets generally accepted scientific principles - Documentation insufficient for thorough assessment

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Mutagenicity and carcinogenicity of mono- and diacetyl hydrazine.
Author:
Bhide SV, Bhalerao EB, Sarode AV, Maru GB.
Year:
1984
Bibliographic source:
Cancer Lett. 1984 Jun;23(2):235-40.
Reference Type:
publication
Title:
The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Author:
Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JA.
Year:
1990
Bibliographic source:
Mutat Res. 1990 Jul;239(1):29-80.

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
yes
Remarks:
: 4 animals per dose, 2 treatments at an interval of 24 h, single sampling 6 h after last treatment.
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N'-diacetylhydrazine
EC Number:
221-576-1
EC Name:
N,N'-diacetylhydrazine
Cas Number:
3148-73-0
Molecular formula:
C4H8N2O2
IUPAC Name:
N'-acetylacetohydrazide
Details on test material:
- Name of test material (as cited in study report): diacetyl hydrazine (DAH)
- Physical state:
• diacetylhydrazine: not reported
- Analytical purity:
• diacetylhydrazine: not reported
- Impurities (identity and concentrations):
• diacetylhydrazine: not reported
- Composition of test material, percentage of components:
• diacetylhydrazine: not reported
- Provider: Ega Chemie, Germany (nowadays Sigma-Aldrich)

Test animals

Species:
mouse
Strain:
Swiss
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS

- Age at study initiation: 6 - 8 weeks
- Weight at study initiation: 20 - 30 g

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
- Vehicle(s)/solvent(s) used: none
- Justification for choice of solvent/vehicle: N/A
Details on exposure:
APPLICATION
- ip injection of pure diacetylhydrazine: at 2400 mg/kg bw/d

Duration of treatment / exposure:
- twice, at an interval of 24 h
Frequency of treatment:
- twice, at an interval of 24 h
Post exposure period:
not applicable animals sacrificed 6 h after last dosing
Doses / concentrations
Remarks:
Doses / Concentrations:
2400 mg/kg bw/d of diacetylhydrazine
Basis:
other: actual injected
No. of animals per sex per dose:
4 males per dose
Control animals:
other: yes, concurrent treatment with 0.2 mg water/animal
Positive control(s):
Monoacetyl hydrazine was tested in parallel and showed positive results. It can be regarded as a positive control.

Examinations

Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION:
- Based on LD50 values of 3000 mg diacetyl hydrazine/kg bw in mice

DETAILS OF SLIDE PREPARATION:
- bone marrow preparations
- stained in May-Grunwald Giemsa
- mounted in Euparol

METHOD OF ANALYSIS:
- 4000 polychromatic and normochromatic erythrocytes scored per animal

OTHER:
Evaluation criteria:
not reported
Statistics:
Results are mean ± S.E. of 4 animals in each group.

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Remarks:
for diacetylhydrazine
Toxicity:
no effects
Remarks:
, based on an unaffected ratio of polychromatic cells/normochromatic cells as compared to negative control
Vehicle controls validity:
not specified
Negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- no range finding study reported

RESULTS OF DEFINITIVE STUDY
- acetylhydrazine: significant increase in the frequency of micronuclei in the polychromatic erythrocyte.
- diacetylhydrazine: no significant increase in the frequency of micronuclei in the polychromatic erythrocyte.

Any other information on results incl. tables

- Table 1: mutagenicity of DAH using the micronucleus test

No.

Compound

Dose/ 

animal (mg)

% Polychromatic  

erythrocytes

with micronucleus

P/N  

ratio (a)

1

Distilled water

0.2

0.25 ± 0.05

1.0

2

DAH

48

0.36 ± 0.03

1.1

Results are expressed as mean ± S.E. of 4 animals in each group.

(a) P/N ratio, ratio of polychromatic to normochromatic cells.

*Statistically significant when compared with controls, P < 0.05.

Applicant's summary and conclusion

Conclusions:
Interpretation of results: negative
Diacetylhydrazine was tested for it's potential to cause chromosome abberations in an in vivo micronucleus test in Swiss mice 2400 mg/kg bw ip injected twice, conducted comparable to OECD 474. No adverse effects were seen for diacetylhydrazine at the tested dose. Accordingly diacetylhydrazine (DAH) is deemed negative for in vivo chromosome abberation in this test system.
Though the details reported are too limited for a solid assessment, the results are deemed relevant and sufficient as supporting information.
Executive summary:

In the study Bhide (1984) diacetylhydrazine were tested for their potential to cause chromosome abberations in an in vivo micronucleus test in Swiss mice at 2400 mg/kg bw ip injected twice, conducted comparable to OECD 474.

4 male Swiss mice per dose were used and the animal were treated twice at an interval of 24 h. Sampling was conducted once, 6 h after the last treatment. Bone marrow preparations were made, stained in May-Grunwald Giemsa and mounted in Euparol. 4000 polychromatic and normochromatic erythrocytes were scored per animal.

No adverse effects were seen for diacetylhydrazine at the tested dose. Accordingly diacetylhydrazine (DAH) is deemed negative for in vivo chromosome abberation in this test system.

Though the details reported are too limited for a solid assessment, the results are deemed relevant and sufficient as supporting information.